Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol)

Giyoong Tae, Julia A. Kornfield, Jeffrey A. Hubbell

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn2+ ions without protein aggregation or initial burst.

Original languageEnglish
Pages (from-to)5259-5266
Number of pages8
JournalBiomaterials
Volume26
Issue number25
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Hydrogels
Ethylene Glycol
Human Growth Hormone
Hydrogel
Hormones
Self assembly
Polyethylene glycols
Organic solvents
Injections
Proteins
Fluorocarbons
Agglomeration
Gels
Hydrophobic and Hydrophilic Interactions
Ions
Water
Liquids

Keywords

  • Diffusion
  • Human growth hormone
  • In situ forming
  • Sustained release

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). / Tae, Giyoong; Kornfield, Julia A.; Hubbell, Jeffrey A.

In: Biomaterials, Vol. 26, No. 25, 01.09.2005, p. 5259-5266.

Research output: Contribution to journalArticle

Tae, Giyoong ; Kornfield, Julia A. ; Hubbell, Jeffrey A. / Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). In: Biomaterials. 2005 ; Vol. 26, No. 25. pp. 5259-5266.
@article{e5f792ee265a49af9db144a623e09a47,
title = "Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol)",
abstract = "Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn2+ ions without protein aggregation or initial burst.",
keywords = "Diffusion, Human growth hormone, In situ forming, Sustained release",
author = "Giyoong Tae and Kornfield, {Julia A.} and Hubbell, {Jeffrey A.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1016/j.biomaterials.2005.01.042",
language = "English",
volume = "26",
pages = "5259--5266",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "25",

}

TY - JOUR

T1 - Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol)

AU - Tae, Giyoong

AU - Kornfield, Julia A.

AU - Hubbell, Jeffrey A.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn2+ ions without protein aggregation or initial burst.

AB - Poly(ethylene glycol)s modified with fluorocarbon end groups are capable of in situ transition from an injectable liquid to a viscoelastic hydrogel by hydrophobic interaction of the end groups; this class of materials is useful for a variety of biomedical applications, including sustained protein release. The hydrogel state can be transformed into an injectable state by the addition of a toxicologically acceptable organic solvent, such as N-methyl pyrrolidone; after injection, this solution quickly returns to a gel state by diffusion of the water-miscible organic solvent into the surrounding environment. In vitro characterization of sustained release of human growth hormone (hGH) using this injectable depot shows that hGH remains stable inside the hydrogel formed, and demonstrates more than 2 weeks of prolonged release of hGH complexed with Zn2+ ions without protein aggregation or initial burst.

KW - Diffusion

KW - Human growth hormone

KW - In situ forming

KW - Sustained release

UR - http://www.scopus.com/inward/record.url?scp=15244349102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=15244349102&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2005.01.042

DO - 10.1016/j.biomaterials.2005.01.042

M3 - Article

VL - 26

SP - 5259

EP - 5266

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 25

ER -